ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com